ArticleBiological trace element research2026
Combined Supplementation OF Magnesium AND Boron Ameliorate Menopause-Associated Osteogenic Disturbances in Ovariectomized Rats.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to a deficit of estrogen, menopausal women often suffer from osteoporosis, resulting in impaired productivity and quality of life. Although estrogen replacement therapy may alleviate osteoporosis associated with menopause, it can also have harmful effects. Magnesium aids bone mineralization, while boron supports bone structure. Thus, this work explored for the first time the impact of magnesium and boron on osteogenic markers in ovariectomized rats. Thirty adult female rats were equally distributed into five groups: sham-operated, ovariectomized, ovariectomized + magnesium, ovariectomized + boron, and ovariectomized + magnesium + boron. Bone health was also evaluated by measuring bone mineral density (BMD) as well as serum and bone contents of calcium, phosphorus, and magnesium. Serum 25-hydroxyvitamin D, parathormone, and osteocalcin were also assessed along with bone alkaline phosphatase. Results indicated that ovariectomy significantly reduced BMD, serum and bone minerals, and serum 25-hydroxyvitamin D levels compared to Sham values. Additionally, it raised serum parathormone levels and bone turnover markers. However, all osteogenic parameters were markedly improved by individual and combined supplementation of rats with magnesium and boron. Notably, combining both minerals outperformed individual intake, implying their promising efficacy in maintaining bone health during menopause. Further large-scale research and clinical trials should be conducted to confirm the collaborative impact of magnesium and boron and determine safe and optimal doses and regimens.
Indexed as
Identifiers
41075129What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.